Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5344

5 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Atorvastatinfigure1 (Atorvastatinfigure1)
Chemical structure of atorvastatin calcium depicted as a detailed molecular diagram showing two identical atorvastatin molecules complexed with calcium and three water molecules.*
FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
A line chart showing cumulative incidence percentage over 3.5 years, comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, and the dashed line represents Placebo, with Atorvastatin group showing a consistently lower cumulative incidence. The chart includes hazard ratio (HR) of 0.64 with a confidence interval (0.50-0.83) and p-value of 0.0005.*
FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
A Kaplan-Meier curve displaying cumulative hazard (%) over time (years) for placebo and Atorvastatin groups during up to 5 years of follow-up. The graph compares the time to first primary endpoint between the two groups, showing a hazard ratio of 0.63 with confidence intervals and a p-value of 0.001.*
FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
A line chart comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event. Two lines represent the two doses, with a hazard ratio (HR) of 0.78 (0.69-0.89) and p-value of 0.0002 indicated on the chart.*
FDA Label Image

Pdp (68071 5344 3)

Pdp (68071 5344 3)
Packaging label for Atorvastatin Calcium 10 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label states a 30-tablet count and specifies the tablet as oval, white to off-white, debossed with '10' on one side and 'A53' on the other. Includes NDC 68071-5344-3 and various manufacturing and lot details. Storage instructions recommend 68-77°F.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.